Lumos Pharma Inc (LUMO)
4.30
-0.06
(-1.38%)
USD |
NASDAQ |
Nov 13, 16:00
4.30
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma 1 Year Total Returns (Daily): 38.71% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 38.71% |
November 12, 2024 | 50.34% |
November 11, 2024 | 50.69% |
November 08, 2024 | 8.17% |
November 07, 2024 | 18.82% |
November 06, 2024 | 23.14% |
November 05, 2024 | 25.79% |
November 04, 2024 | 26.50% |
November 01, 2024 | 21.39% |
October 31, 2024 | 20.00% |
October 30, 2024 | 19.56% |
October 29, 2024 | 15.92% |
October 28, 2024 | 18.04% |
October 25, 2024 | 10.28% |
October 24, 2024 | 8.75% |
October 23, 2024 | 15.65% |
October 22, 2024 | 8.52% |
October 21, 2024 | 2.48% |
October 18, 2024 | -4.29% |
October 17, 2024 | -9.57% |
October 16, 2024 | -6.09% |
October 15, 2024 | -4.09% |
October 14, 2024 | -6.25% |
October 11, 2024 | -11.03% |
October 10, 2024 | -4.63% |
Date | Value |
---|---|
October 09, 2024 | -7.23% |
October 08, 2024 | -3.26% |
October 07, 2024 | -3.02% |
October 04, 2024 | -15.11% |
October 03, 2024 | 1.67% |
October 02, 2024 | 5.46% |
October 01, 2024 | 8.79% |
September 30, 2024 | 17.27% |
September 27, 2024 | 36.81% |
September 26, 2024 | 38.13% |
September 25, 2024 | 44.13% |
September 24, 2024 | 33.79% |
September 23, 2024 | 28.33% |
September 20, 2024 | 35.52% |
September 19, 2024 | 30.88% |
September 18, 2024 | 17.46% |
September 17, 2024 | 19.75% |
September 16, 2024 | 19.44% |
September 13, 2024 | 20.55% |
September 12, 2024 | 14.42% |
September 11, 2024 | 9.20% |
September 10, 2024 | 7.25% |
September 09, 2024 | 11.48% |
September 06, 2024 | 12.43% |
September 05, 2024 | 22.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.62%
Minimum
Dec 30 2021
123.6%
Maximum
Dec 26 2019
-21.42%
Average
-24.50%
Median
1 Year Total Returns (Daily) Benchmarks
Boston Scientific Corp | 65.28% |
Calidi Biotherapeutics Inc | -84.28% |
NovaBay Pharmaceuticals Inc | -93.43% |
Palatin Technologies Inc | -40.80% |
iBio Inc | -59.75% |